GI
UTHR icon

GAMMA Investing’s United Therapeutics UTHR Stock Holding History

GAMMA Investing’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$878K Sell
1,621
-148
-8% -$76.5K 0.03% 475
2026
Q2 		$958K Buy
1,769
+165
+10% +$92.9K 0.04% 410
2026
Q1 		$951K Buy
1,604
+108
+7% +$53.8K 0.04% 355
2025
Q4 		$729K Buy
1,496
+349
+30% +$163K 0.04% 405
2025
Q3 		$481K Buy
1,147
+115
+11% +$38.7K 0.03% 521
2025
Q2 		$297K Buy
1,032
+312
+43% +$93.2K 0.02% 679
2025
Q1 		$222K Sell
720
-32
-4% -$11K 0.02% 713
2024
Q4 		$265K Buy
752
+169
+29% +$62.1K 0.02% 587
2024
Q3 		$209K Buy
583
+193
+49% +$65.2K 0.02% 606
2024
Q2 		$124K Buy
390
+179
+85% +$47.4K 0.02% 669
2024
Q1 		$48.5K Buy
211
+12
+6% +$2.71K 0.01% 1065
2023
Q4 		$42.7K Buy
+199
New +$45.9K 0.01% 994

Other funds holding UTHR

AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
BTC
Bank & Trust Company Litchfield, Illinois $159M AUM 30.15% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
SRS
Strong Retirement Solutions Silverdale, Washington $178M AUM 20.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's UTHR Position: Q3 2026 in Review

GAMMA Investing reduced its United Therapeutics (UTHR) stake by 8.4% in Q3 2026, selling an estimated $76.5K and leaving 1,621 shares worth $878K. The position accounts for 0.03% of the portfolio, ranked #475.

GAMMA Investing first reported a position in UTHR in Q4 2023 and has held it in 12 quarters since. The position peaked at $958K in Q2 2026. 17 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • GAMMA Investing held 1,621 shares of United Therapeutics worth $878K as of Q3 2026.
  • GAMMA Investing sold 148 United Therapeutics shares in Q3 2026, an estimated $76.5K.
  • United Therapeutics made up 0.03% of GAMMA Investing's portfolio in Q3 2026, its #475 holding.
  • GAMMA Investing first reported a position in United Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's United Therapeutics position peaked at $958K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.